Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Valeant Pharma (VRX) has right product line

|Includes: Valeant Pharmaceuticals International, Inc. (VRX)

On Financial Tides we give straight forward BUY & SELL signals for your stock investing portfolio. No beating around the bush. Valeant Pharma (NYSE:VRX) is a global research pharmaceutical company that develops, manufacturers and markets specialty drugs, both subscription and OTC. They have a product line of 389 drugs so this is not a one trick pony.

This is a great technical analysis play with BarChart's TA indicators giving 13 BUY signals out of 13 indicators. 9 new highs in the last 20 session and 5 for 5 recently show the stock in trending well. This stock is part of Financial Tides S%P 400 portfolio on Marketocracy. There has been a 26% price appreciation in the last 65 day of trading.

Recommendation: BUY VRX around 28 with a tight stop loss at 26, for a quick TA play.

Jim Van Meerten is an investor who writes his stock investing opinions on Financial Tides,
MSN Top Stock Blog and Seeking Alpha. Please leave your comments below or email to FinancialTides@gmail.com.

Disclosure: I do not own any VRX at the time of publication.